Other projects

Promoting more humane animal research

As part of Parsemus Foundation’s commitment to animal welfare, we’re proud to be a new sponsor of the Janet Wood Innovation Award, which supports the “Three Rs” of animal testing: the REPLACEMENT of animals in testing, the REDUCTION in animal use in testing, and the REFINEMENT of animal testing methods to minimize or avoid animal… Read more


Improved health with new treatment regimen for adrenal insufficiency

If you or someone you know has adrenal insufficiency, you probably understand how difficult it is to regulate glucocorticoid replacement therapy. That’s because the body normally has various levels of cortisol throughout the day as well as in response to stressors. Glucocorticoid over-treatment may result in weight gain and metabolic impairment, with dose reduction the… Read more


New heart stent study: No impact on chest pain

A carefully controlled study has reported that stents given to individuals with a severe blockage of an artery did not improve their pain or their performance in treadmill tests relative to individuals who did not receive stents. The research study, named ORBITA, used a randomization procedure in which half of the participants received a stent… Read more


2017 review of medical overuse

Scientists from the University of Maryland School of Medicine have reviewed the data on various medical procedures and presented an analysis of the most overused medical practices. This study was reported in the “Less is More” series in JAMA Internal Medicine. For more information, see our page on promoting evidence-based medicine. This list is reprinted… Read more


Underutilized nonsurgical treatment for uterine fibroids

Most women have heard about uterine fibroids – benign tumors that affect 70-80% of women at some point in their lives. However, very few women are aware that they can be removed without surgery. The procedure is called uterine fibroid embolization (UFE). A recent survey conducted by the Society of Interventional Radiology reported that 44% of… Read more


Prostate drug linked to serious side effects

A common drug called Avodart (Dutsteride) that is prescribed for benign prostatic hyperplasia (BPH) has been associated with an increased risk for diabetes, elevated cholesterol levels,  liver disease and worsening erectile dysfunction, reports Boston University Medical Center researchers. BPH is a common condition in men as they age, resulting in an enlarged prostate. Men seeking… Read more


Medical procedures continue to be used despite ineffectiveness

Stents for coronary artery disease, Atenolol for blood pressure, surgery for a torn meniscus and many other procedures are likely over-used, explains David Epstein reporting for The Atlantic. Despite evidence that may contradict the effectiveness of common medical procedures, many are still being prescribed by physicians. This in-depth investigative article is a must-read! The author… Read more


Link between Alzheimer’s disease and male hormones

Cognitive dysfunction, including Alzheimer’s disease, has been related to androgen deprivation therapy (ADT). Scientists from Stanford reported that men who were undergoing ADT to treat prostate cancer had significantly increased risk of developing dementia (published in JAMA Oncology). ADT is a common treatment for prostate cancer because the cancer cells usually require androgens, like testosterone,… Read more


The economics of male birth control

A history of male contraceptive development – as experienced and related by our founder Elaine Lissner – was recently covered in a Priceonomics article called “The Economics of Male Birth Control“. Written by Rosie Cima, the article chronicles the life’s work of Ms. Lissner who spent decades advocating for and supporting the development of new male… Read more